ViroMed Co. Ltd. | Mutual Funds
Mutual Funds that own ViroMed Co. Ltd.
Vanguard Total International Stock Index Fund
190,901
1.2%
0
0.01%
07/31/2018
Government Pension Fund - Global (The)
142,209
0.89%
-93,663
0%
12/31/2017
iShares Core MSCI Emerging Markets ETF
119,401
0.75%
0
0.05%
09/05/2018
iShares MSCI South Korea Capped ETF
82,153
0.52%
0
0.45%
09/06/2018
iShares MSCI Emerging Markets ETF
81,150
0.51%
0
0.06%
09/06/2018
Vanguard Developed Markets Index Fund
76,267
0.48%
0
0.02%
07/31/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
58,288
0.37%
523
0%
03/31/2018
Vanguard FTSE All World (ex-US) Small Cap
33,820
0.21%
829
0.11%
07/31/2018
Mirae Asset TIGER Health Care ETF
28,033
0.18%
5,483
4.01%
04/30/2018
Vanguard Investment Series Plc - Emerging Markets Stock Index
25,239
0.16%
25,239
0.06%
07/31/2018
| Address |
203 Bldg. Natural Science College
Seoul SL 08733
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.viromed.co.kr |
| Updated |
09/14/2018 |
| ViroMed Co., Ltd. engages in the development and manufacture of biopharmaceuticals for human diseases. It operates through the Natural Materials and Biomedical Products Business Divisions. Its products include technologies for diseases. |
